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Abstract
The availability of the rat genome sequence, and detailed three-way comparison of the rat, mouse
and human genomes, is revealing a great deal about mammalian genome evolution. Together with
recent developments in cloning technologies, this heralds an important phase in rat research.
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Historically, the rat has been the animal model of choice for
research in key areas that inform human medicine, such as
cardiovascular biology, neurobiology and nutrition. A huge
body of knowledge has accumulated and over 230 disease
models have been generated through selective breeding. The
rat is also an indispensable tool in drug development, both
for the assessment of therapeutic efficacy and for toxicity
trials. The mouse has largely usurped the rat as the species
of choice in biomedical research in general, however,
because of its size, fecundity and ease of genetic manipula-
tion - especially with the development of gene knock-out
technology. After human, the mouse was the obvious next
choice for whole-genome sequencing, and there was a naive
belief that the rat genome sequence would prove to be
redundant, given the morphological and evolutionary simi-
larity between the rat and the mouse.
The recent publication in Nature of an initial rat genome-
sequence analysis [1] has gone a long way to silence doubters
and to inspire the rat research community. Using a combina-
tion of random whole-genome shotgun sequencing and a
bacterial artificial chromosome (BAC) contig-building
approach, a high-quality draft of the Brown Norway rat
sequence, covering over 90% of the genome, has been
achieved by the Rat Genome Sequencing Project Consortium
- led by the Baylor College of Medicine (Houston, USA), and
including Celera Genomics (Rockville, USA), Genome Ther-
apeutics (Waltham, USA) and many academic centers world-
wide. A three-way comparison of the rat sequence with the
human and mouse genomes has revealed a great deal of new
information about mammalian genome evolution. The rat
genome (2.75 gigabases, Gb) is smaller than the human
genome (2.9 Gb) but larger than that of the mouse (2.6 Gb).
Global comparison of the three genomes reveals large chro-
mosomal regions, referred to as orthologous chromosomal
segments, which have been inherited with minimal
rearrangement of gene order from the primate-rodent ances-
tor. These intact regions have become interspersed during
large-scale chromosomal rearrangements since the separa-
tion of primate and murid ancestors approximately 75
million years ago, and since the split between rat and mouse
12-24 million years ago. Comparison of present day chromo-
somal configurations allows one tentatively to reconstruct
the sequence and timing of the rearrangements, and con-
firms that the rate of rearrangements in murid rodents is
much higher than in the primate lineage. 
Large segmental repeats make up about 3% of the rat
genome, a value intermediate between the mouse (1-2%) and
human genomes (5-6%). These duplicated regions are
enriched near telomeres and centromeric regions, and are
associated with the recent expansion of major gene families.
About 40% of the euchromatic rat genome aligns with both
mouse and human sequences and thus represents the ances-
tral core; this core contains about 95% of the known coding
exons and non-coding regulatory regions, both of which char-
acteristically accumulate substitutions at a slower rate than
‘neutral’ DNA, indicating their critical role. Conservation
within three mammalian genomes has proved to be
extremely useful for identifying non-coding regulatory ele-
ments, including transcription-factor binding sites and locus-
control regions. Searching the human genome for 109
transcription-factor binding sites revealed over 186,000,000
potential sites. When conservation between the three genomes
was a pre-requisite for a potential site, however, the number
was reduced to 4,000,000, representing a 44-fold increase in
specificity. Such analyses should aid in the location of
enhancer sequences, boundary elements, and perhaps even
matrix-attachment sites (at which DNA is thought to bind to
chromosomal scaffolds). Given the long distances over
which control elements act, apparent ‘gene deserts’ (gene-
poor regions larger than 500 kilobases), which make up
approximately 25% of the human genome, may prove to be a
fertile source of important gene-regulatory elements [2].
The three mammalian genomes contain multiple copies of
immobilized transposable elements, which constitute 40% of
the mouse and rat genomes, and almost 50% of the human
[1]. The long interspersed nucleotide element LINE-1 was
active before the rodent-primate split, and over half a
million copies, in various stages of decay, can still be recog-
nized in the rat. Since the rat-mouse split, the L1 retrotrans-
poson has remained active, and represents 12% of the rat
genome and 10% of the mouse genome. Looking at rat
euchromatin, 28% aligns only with mouse, and 40% of this
consists of rodent-specific repeats, such as B2 SINEs (short
interspersed nucleotide elements), which are still active, and
the extinct B4 element. The Alu-like B1 element is still active
in the mouse but probably became extinct in the rat soon
after the mouse-rat split. On the other hand, the ID element,
which is relatively minor in the mouse, is present in over
160,000 copies in the rat. The remainder of the euchromatic
rat genome includes rat-specific repeats or rodent-specific
repeats that have been lost from the mouse genome. 
Rodent lineages have acquired more genomic changes than
primates, including a three-fold higher rate of base substitu-
tion in neutral DNA. Interestingly, the rate of base substitu-
tion is 5-10% higher in the rat than the mouse branch,
leading to a relative increase in GC content in the rat; and
the rat has also accumulated microdeletions more rapidly
than the mouse. Such biochemical changes may reflect
increased recombination rates, and differences in repair and
replication enzymes. One particular type of non-coding
sequence, namely pseudogenes, is not subject to selective
constraint, so pseudogenes accumulate sequence modifica-
tions neutrally. Approximately 20,000 pseudogenes were
identified in the rat genome, a similar number to that found
in human and mouse. The largest groups of pseudogenes
have arisen from ribosomal-protein genes, olfactory recep-
tors, glyceraldehyde 3-phosphate dehydrogenase, protein
kinases and RNA-binding RNP-1 proteins. A large propor-
tion of the pseudogenes (80%) is not found in human-rat
syntenic regions and are probably retrotransposed and
processed. In addition, when looking at coding sequences,
analysis of in-frame changes to proteins suggests that
trinucleotide repeats accumulated more often in secreted
and nuclear proteins, transcription regulators and ligand-
binding proteins, than in cytoplasmic and mitochondrial
proteins. Transmembrane domains were found to be partic-
ularly refractory to trinucleotide accumulation (six-fold
lower than would be expected if due to chance). 
The three mammalian genomes have been predicted to encode
similar numbers of genes [1] and it is estimated that 90% of
rat genes have orthologs in the mouse and human genomes
that have persisted since they shared a common ancestor. The
remaining genes are associated with gene-family expansions -
a major source of genetic differences between the rat and the
mouse - reflecting differences in chemosensation and aspects
of reproduction. Detailed analysis of olfactory receptors, for
example, indicates that the rat contains a potential olfactory
repertoire of around 1,400 proteins. This is significantly more
than the approximately 1,200 mouse olfactory receptors,
although any functional implications for the animals’ relative
ability to discriminate odorants are not known at present.
Another class of odorant-binding proteins, the 2u-globulin
pheromone-binding proteins have also undergone gene-
family expansion. The orthologous human genomic region
possesses a single homolog, probably mirroring the common
rodent-primate ancestor, while the C57BL/6J mouse has
four homologous genes (the major urinary proteins, MUPs)
and seven pseudogenes. The rat genome contains 10
2u-globulin genes and 12 pseudogenes in one of several
gene clusters, which have arisen by gene duplication since
the rat-mouse split. Rapid evolution has also been observed
in protease and protease-inhibitor genes, and also in the
cytochrome P450 family of proteins. The latter are involved
in the metabolism of both endogenous and toxic com-
pounds. Given that rats are an important model for human
drug metabolism and toxicity trials, it is essential to be
aware of this species-specific variation in P450 subfamilies
because it may have a significant bearing on such trials. 
More than 1,000 human disorders that show Mendelian
inheritance have been associated with specific gene loci, and
these were compared with predicted rat genes. For over 75%
of the disease genes, a 1:1 rat ortholog was predicted by
Ensembl [3], and of the remaining 25%, the vast majority had
likely orthologs among genomic, cDNA, expressed sequence
tag (EST) and protein sequences. This suggests that, as a
class, disease genes have been highly conserved since the
rodent-primate split. When the genes were grouped by
disease type, the neurological gene set exhibited fewer non-
synonymous base substitutions than neutral DNA (suggest-
ing the presence of selective constraints), whereas genes
whose associated disease was classed as pulmonary, hemato-
logical or immunological manifested higher non-synonymous
base substitution rates than neutral DNA, indicating positive
selection or reduced constraints. These differences reflect
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different evolutionary rates for the various disease systems.
Multigenic disorders are investigated in humans using asso-
ciation studies and linkage analyses. With better definition
of syntenic boundaries as a result of comparative genomic
analysis, it may now be possible to narrow down the identity
of candidate gene(s) and/or functional non-coding sequences
within quantitative-trait loci. Recently developed consomic
rat lines, in which an entire chromosome from one inbred
strain is introgressed onto the background of a second
inbred strain [4], congenic strains and recombinant inbred
strains [5] can all be used to complement these studies, as
can microarray technology. 
Finally, one should consider the problem of assigning a func-
tion to all the genes identified by genome sequencing. One of
the most effective means of determining gene function is by
a targeted knock-out of the gene. Although this technology
has proved elusive in the rat, random mutagenesis, by treat-
ment of adult rats with ethylnitrosourea (ENU) [6], has suc-
cessfully generated ‘knock-out’ rats. Mutations in target
genes were identified in the F1 offspring of the ENU-treated
adults using PCR combined with a yeast selection assay.
Even more encouraging is the report that blastocyst-derived
cells resembling rat embryonic stem (ES) cells have been
maintained in culture for over 50 passages [7]. This is cer-
tainly long enough for targeted genetic modifications to be
introduced, and given recent advances in nuclear transfer in
the rat [8], the possibility of gene targeting by a combination
of these techniques is tantalizingly close. In conclusion, the
rat genome sequence is already proving its worth! The rat is
not just a big mouse - it can now begin to take its rightful
place in functional genomics and integrative physiology. 
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